Marcus Noel is an Oncologist and a Hospital Medicine provider in Washington, Washington, D.c.. Dr. Noel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, and Tissue Biopsy.

John Marshall is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Marshall is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Hepatectomy, and Pancreatectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.

Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Pancreaticoduodenectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Gliosarcoma, Astrocytoma, Posterior Fossa Tumor, and Endometrial Cancer.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Quyen Chu is a Surgical Oncologist and a General Surgeon in Washington, Washington, D.c.. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Breast Cancer, Pancreatic Cancer, Colorectal Cancer, Mastectomy, and Pancreatectomy. Dr. Chu is currently accepting new patients.

Keith Unger is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Unger is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Anal Cancer, and Adult Soft Tissue Sarcoma. Dr. Unger is currently accepting new patients.

Benjamin Weinberg is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Weinberg is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Vertebroplasty, and Colonoscopy. Dr. Weinberg is currently accepting new patients.

Raffaele Girlanda is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Girlanda is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Alcoholic Cirrhosis, Atypical Hemolytic Uremic Syndrome (aHUS), Pancreatoblastoma, Liver Transplant, and Ileostomy.

Thomas Fishbein is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Fishbein is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Bile Duct Cysts, Pancreatic Cancer, Liver Cancer, Liver Transplant, and Pancreatectomy. Dr. Fishbein is currently accepting new patients.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Lynt Johnson is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Bile Duct Cysts, Pancreatic Cancer, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Jeffrey Lukish is a Pediatric Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Lukish is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pectus Excavatum, Urachal Cyst, Umbilical Hernia, Hepato-Pancreato-Biliary Surgery, and Endoscopy. Dr. Lukish is currently accepting new patients.

Anteneh Tesfaye is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Tesfaye is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Anal Cancer, Lynch Syndrome, Pancreatic Ductal Adenocarcinoma, and Fibrolamellar Carcinoma. Dr. Tesfaye is currently accepting new patients.

David Perry is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Perry is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, and Pancreatic Cancer.

Timothy Kennedy is a Surgical Oncologist and a General Surgeon in Washington, Washington, D.c.. Dr. Kennedy is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Stomach Cancer, Colorectal Cancer, Familial Colorectal Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Kennedy is currently accepting new patients.

Cal Matsumoto is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Matsumoto is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Short Bowel Syndrome, Malnutrition, Pancreatoblastoma, Ileostomy, and Liver Transplant. Dr. Matsumoto is currently accepting new patients.

Yuri Genyk is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Genyk is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Cholestasis, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy.